Acquisition Expands Decision Resources Group’s Consulting Capabilities
Company’s Name Change to Decision Resources Group to Better Reflect Organic and Acquisition Growth Strategy
July 25, 2011—Burlington, Mass. and Flemington, N.J.—Decision Resources Group (previously known as Decision Resources, Inc.), one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired PharmaStrat, the leading consulting and market research services firm focused on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. The acquisition of Flemington, N.J.-based PharmaStrat by Burlington, Mass.-based Decision Resources Group will result in a significant expansion of Decision Resources Group’s market access capabilities.
PharmaStrat’s focus on innovative methodological approaches, the integration of those approaches and multi-stakeholder insights sets the firm apart in the industry.
“We are excited to continue our growth as a Decision Resources Group company,” said Phil Patrick, founder of PharmaStrat. “We look forward to continuing to expand our portfolio of client offerings by leveraging the rich intellectual capital at Decision Resources Group.”
Reimbursement issues and customer segmentation are high priorities for biopharmaceutical organizations and, as markets get more competitive, guidance on these issues from industry-leading experts is critical.
“PharmaStrat is an important acquisition in Decision Resources Group’s overall strategy to expand our market access capabilities and offer our clients the most innovative, high-value advisory solutions,” said Peter Hoenigsberg, CEO of Decision Resources Group. “Positioning drug brands in a way to maximize reimbursement has become quite possibly the most significant issue for pharmaceutical companies today. PharmaStrat brings to Decision Resources Group unparalleled expertise in this area.”
PharmaStrat will remain headquartered in Flemington, N.J.
Name Change Better Reflects Growth and Vision
Decision Resources, Inc. has changed its name to Decision Resources Group. The name change better reflects the organic and acquisition growth strategy that is the mainstay of the Company’s vision.
PharmaStrat is the leading consulting and market research services firm focused exclusively on issues related to reimbursement and organized customer segments for biopharmaceutical manufacturers. Founded in 2002, PharmaStrat continues to experience strong growth and was recently recognized for the third year as one of Inc. Magazine’s Fastest Growing Private Companies in the U.S. For more information on PharmaStrat, please visit www.PharmaStrat.com.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, insights, advisory services and consulting on important sectors of the healthcare industry. Clients rely on this analysis, data and consulting services to make more informed critical management decisions. With over 450 employees worldwide, analysts at Decision Resources Group companies provide the pharmaceutical, biotech, medical device, financial services and managed care industries with the analytics and advice they need to compete and thrive in an increasingly competitive marketplace. Through both organic growth and an aggressive acquisition strategy, Decision Resources Group has become the premier provider of healthcare analysis, data and advisory services in the world. Visit Decision Resources Group at www.DecisionResourcesGroup.com.
For more information, contact:
Decision Resources Group
Return to Press Releases